ProMIS Neurosciences, Inc.
PMN
$10.57
$0.080.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 213.78% | 231.87% | 196.52% | 115.16% | 34.95% |
| Gross Profit | -213.78% | -231.87% | -196.52% | -115.16% | -34.95% |
| SG&A Expenses | 9.67% | 14.61% | 23.18% | 2.48% | -2.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 138.70% | 140.80% | 119.69% | 58.93% | 17.98% |
| Operating Income | -138.70% | -140.80% | -119.69% | -58.93% | -17.98% |
| Income Before Tax | -1,529.36% | -5,097.59% | 30.92% | 92.14% | 121.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,529.36% | -5,097.59% | 30.92% | 92.14% | 121.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,529.36% | -5,097.59% | 30.92% | 92.14% | 121.03% |
| EBIT | -138.70% | -140.80% | -119.69% | -58.93% | -17.98% |
| EBITDA | -- | 59.11% | 18.25% | -1.48% | -18.01% |
| EPS Basic | -5,317.67% | -286.76% | 71.26% | 95.00% | 98.63% |
| Normalized Basic EPS | -1,178.27% | -234.57% | 85.77% | 107.13% | 106.86% |
| EPS Diluted | -4,867.83% | -289.08% | 71.03% | 94.81% | 98.50% |
| Normalized Diluted EPS | -1,183.98% | -233.81% | 85.71% | 107.07% | 106.83% |
| Average Basic Shares Outstanding | 75.70% | 72.48% | 88.80% | 98.87% | 112.04% |
| Average Diluted Shares Outstanding | 75.62% | 72.39% | 88.86% | 98.94% | 112.13% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |